Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Clinical trial NCT00526669 · COMPLETED

Trial details

NCT number: NCT00526669
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Gastrointestinal Tract

Start date: 2008-03-01
Primary completion: 2011-04-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.